Popular search terms:
Search Results Label
33 results found-
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION AFLURIA® TETRA Quadrivalent Inactivated Influenza Vaccine (Split Viri...
No interaction studies have been performed on interaction between influenza vaccines in general and other vaccines or medications.
https://www.seqirus.ca/-/media/seqirus-canada/docs-en/afluria-tetra-product-monograph--7-april-2020.pdf -
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION FLUCELVAX® QUAD Influenza Vaccine (surface antigen, inactivated, prep...
Reproductive and developmental toxicology data from trivalent influenza vaccines do not predict an increased risk of developmental abnormalities.
https://www.seqirus.ca/-/media/seqirus-canada/docs-en/flucelvax-quad-pm-22-nov-2019.pdf -
Agriflu CA ASU Product Monograph
Table 8 CHMP (European) and CBER (US) Criteria for Evaluation of Influenza Vaccines
https://www.seqirus.ca/-/media/seqirus-canada/docs-en/2019-agriflu-product-monograph-19aug2019.pdf -
Fluad Ped-Fluad ASU Product Monograph
Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines.
https://www.seqirus.ca/-/media/seqirus-canada/docs-en/fluad-product-monograph-17june2019.pdf -
Seqirus announces Health Canada approval of first cell-based seasonal influenza vaccine
Seqirus announces Health Canada approval of first cell-based seasonal influenza vaccine
https://www.seqirus.ca/news/seqirus-announces-health-canada-approval-of--first-cell-based-seasonal-influenza-vaccine -
Seqirus | About Us
Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.
https://www.seqirus.ca/our-company -
Seqirus | Our Products
Seqirus is a world leader in developing and producing influenza vaccines. Learn more about how we work with our partners to protect the global community.
https://www.seqirus.ca/products -
MONOGRAPHIE DE PRODUIT MD AGRIFLU
Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines.
https://www.seqirus.ca/-/media/seqirus-canada/docs-fr/2019-agriflu-monographie-de-produit-aug-19-2019.pdf -
Seqirus | A World Leader in Influenza Vaccines
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
https://www.seqirus.ca/ -
US0258396
Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines.
https://www.seqirus.ca/-/media/seqirus-canada/docs-fr/fluad-monogprahie-de-produit--jun-17-2019.pdf